| Literature DB >> 27916832 |
Jun Mao1, Mohamed Aqiel Dalvie2.
Abstract
Data on growth and sexual maturation among boys from the rural Western Cape in South Africa is limited. A cross-sectional study of 269 school boys was conducted testing for serum luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone, sex hormone binding globulin (SHBG) and estradiol (E2); height, weight and body mass index (BMI); sexual maturity (using Tanner Stages) and a questionnaire (demographic and medical history). The median age at pubertal onset (Tanner Stage 2) and Tanner Stage 5 was 11.6 and 14.7 years, respectively. The median testicular volume was 5.5 mL at Tanner Stage 2 increasing from 2.5 mL at Tanner Stage 1 to 14.7 mL at Tanner Stage 5. Height and weight measurements were <25th &amp; 50th percentile references at Tanner Stages 1-3. Controlling for confounders, serum FSH and LH increased (p < 0.05) from Tanner Stage 1 to 4 (by 4.1 and 3 mL respectively), and serum testosterone and estradiol increased after Tanner Stage 2 (by 12.7 nmol/L and 59.5 pmol/L respectively). These results indicate some delays in pubertal development of boys in the rural Western Cape when compared to boys from other settings possibly due to nutritional, socio-economic and environmental exposures. Changes in serum hormone levels were consistent with other populations. Initiatives to improve nutrition amongst Western Cape rural communities are recommended.Entities:
Keywords: boys; growth; reproductive hormones; rural; sexual development
Mesh:
Substances:
Year: 2016 PMID: 27916832 PMCID: PMC5201326 DOI: 10.3390/ijerph13121185
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Participation, demographic characteristics, socioeconomics information.
| Variables | Median (Interquartile Range) |
|---|---|
| Age (years), ( | 11.58 (9.42; 13.17) |
| Monthly Household Income (Rands), ( | 2000 (1300; 2720) |
| Birth weight (kg), ( | 2.9 (2.51; 3.3) |
| Lifetime Residential Location | |
| Farm | 177 (65.80%) |
| Non-farm | 92 (34.20%) |
| Number of Boys within each Tanner Stage | |
| Tanner Stage 1 | 107 (39.78%) |
| Tanner Stage 2 | 78 (29.00%) |
| Tanner Stage 3 | 39 (14.50%) |
| Tanner Stage 4 | 36 (13.38%) |
| Tanner Stage 5 | 8 (2.97%) |
| General Health | |
| Good to Excellent | 259 (96.3%) |
| Poor | 10 (3.7%) |
| Medical History (Lifetime) | |
| Diabetes | 2 (0.7%) |
| Tuberculosis | 15 (5.6%) |
| Epilepsy | 3 (1.1%) |
| Asthma | 25 (9.3%) |
| Heart Problem | 2 (0.7%) |
| HIV | 1 (0.4%) |
| Foetal Alcohol Syndrome | 2 (0.7%) |
| Mumps | 79 (29.3%) |
| Pesticide poisoning | 2 (0.7%) |
| Testicular Related Problems | |
| Born with abnormal testes | 12 (4.5%) |
| Previous testicular injury | 8 (3.0%) |
| Previous testicular operation | 5 (1.9%) |
| Reported testicular disease | 7 (2.6%) |
Mean and interquartile range of age, testicular volume, anthropometric variables and reproductive hormone levels per tanner stage amongst boys in the rural Western Cape.
| Tanner Stage Variable | Tanner Stage 1 | Tanner Stage 2 | Tanner Stage 3 | Tanner Stage 4 | Tanner Stage 5 |
|---|---|---|---|---|---|
| Age (Year) | 9.3 (8.8; 10.7) | 11.7 * (10.4; 12.8) | 13.1 * (12.5; 13.9) | 13.9 * (13.0; 15.0) | 14.7 (12.9; 15.5) |
| Testicular Volume (mL) | 2.5 (2.5–3.5) | 5.5 * (4.0–9.0) | 15.0 * (11.0–17.5) | 20.0 * (17.5–22.5) | 22.5 (17.5–22.5) |
| Anthropometric Variables | |||||
| Height (cm) | 128.5 (124.0–135.0) | 137.2 * (131.2–141.5) | 149.7 * (144.4–159.0) | 162.0 * (153.8–166.5) | 165.5 (165.1–174.0) |
| Weight (kg) | 27.0 (24.0–32.0) | 32.0 * (29.0–37.0) | 42.0 * (39.0–48.0) | 49.0 * (45.0–54.5) | 57.0 * (51.5–64.0) |
| BMI (kg2/cm) | 16.64 (15.23–18.12) | 17.25 (15.55–18.30) | 18.50 * (17.23–22.21) | 18.77 (17.76–20.64) | 20.90 (19.17–23.44) |
| Reproductive Hormones | |||||
| FSH (IU/L) | 0.9 (0.5–1.5) | 1.9 * (1.3–3.1) | 3.1 * (2.3–4.9) | 5.0 * (3.2–7.5) | 3.4 (3.2–7.0) |
| LH (IU/L) | 0.05 (0.05–0.2) | 0.7 * (0.2–1.0) | 1.65 * (1.3–2.1) | 3.0 * (1.8–4.2) | 2.8 (1.9–3.8) |
| Testosterone (nmol/L) | 0.05 (0.05–0.1) | 0.2 (0.05–0.6) | 3.9 * (1.6–8.4) | 10.45 * (5.4–13.6) | 12.9 * (10–18.9) |
| Oestradiol (pmol/L) | 31.5 (23.1–45.5) | 40.45 (29.7–50.4) | 56.5 * (46.1–72.2) | 79.35 * (61.5–88.5) | 100.9 * (87.2–115.2) |
| SHBG (nmol/L) | 121.8 (92.9–145.6) | 104.8 * (86.7–129.6) | 67.5 * (54–78.7) | 44.9 * (37.6–50.2) | 46.2 (36.6–55.2) |
* p < 0.05 compared to the previous Tanner Stage (Linear Regression Analysis). BMI: Body mass index; FSH: follicle stimulating hormone; LH: luteinizing hormone; SHBG: sex hormone binding globulin.
Multivariate association between anthropometric variables and tanner stage for boys from the rural Western Cape after adjusting for lived on farm or not, family income, birth weight, general health condition, prenatal exposures, and testicular related problems.
| Outcomes | B-Coefficient | 95% Confidence Interval | ||
|---|---|---|---|---|
| Height | ||||
| Tanner Stage 2 vs. Stage 1 | 185 | <0.001 | 7.536 | (4.871; 10.201) |
| Tanner Stage 3 vs. Stage 2 | 117 | <0.001 | 13.804 | (10.122; 17.486) |
| Tanner Stage 4 vs. Stage 3 | 75 | <0.001 | 8.576 | (3.931; 13.222) |
| Tanner Stage 5 vs. Stage 4 | 44 | 0.296 | 3.725 | (−3.280; 10.729) |
| Weight | ||||
| Tanner Stage 2 vs. Stage 1 | 185 | <0.001 | 3.956 | (1.796; 6.115) |
| Tanner Stage 3 vs. Stage 2 | 117 | <0.001 | 11.911 | (8.927; 14.895) |
| Tanner Stage 4 vs. Stage 3 | 75 | 0.014 | 4.737 | (0.972; 8.502) |
| Tanner Stage 5 vs. Stage 4 | 44 | 0.012 | 7.295 | (1.618; 12.972) |
| BMI | ||||
| Tanner Stage 2 vs. Stage 1 | 185 | 0.446 | 0.321 | (−0.507; 1.149) |
| Tanner Stage 3 vs. Stage 2 | 117 | <0.001 | 2.270 | (1.126; 3.414) |
| Tanner Stage 4 vs. Stage 3 | 75 | 0.706 | −0.276 | (−1.720; 1.167) |
| Tanner Stage 5 vs. Stage 4 | 44 | 0.109 | 1.775 | (−0.401; 3.951) |
Comparison of anthropometric measurements with CDC and WHO charts.
| Height, Weight and BMI < 25th & 50th Percentile over Each Tanner Stage | Vs. CDC Growth Chart | Vs. WHO Growth Chart |
|---|---|---|
| Body Mass Index | ||
| ≤50th percentile for age | 138 (51.49%) | 116 (43.28%) |
| Tanner Stage 1 | 54 (50.47%) | 44 (41.12%) |
| Tanner Stage 2 | 46 (58.97%) | 42 (53.85%) |
| Tanner Stage 3 | 16 (41.03%) | 14 (35.90%) |
| Tanner Stage 4 | 19 (52.78%) | 13 (36.11%) |
| Tanner Stage 5 | 3 (37.50%) | 3 (37.50%) |
| ≤25th percentile for age | 74 (27.61%) | 64 (23.88%) |
| Tanner Stage 1 | 32 (29.91%) | 29 (27.10%) |
| Tanner Stage 2 | 27 (34.62%) | 24 (30.77%) |
| Tanner Stage 3 | 7 (17.95%) | 6 (15.38%) |
| Tanner Stage 4 | 7 (19.44%) | 5 (13.89%) |
| Tanner Stage 5 | 1 (12.50%) | 0 (0.00%) |
| Height | ||
| ≤50th percentile for age | 194 (72.39%) | 179 (66.30%) |
| Tanner Stage 1 | 83 (77.57%) | 76 (70.37%) |
| Tanner Stage 2 | 64 (82.05%) | 60 (76.92%) |
| Tanner Stage 3 | 25 (64.10%) | 22 (56.41%) |
| Tanner Stage 4 | 17 (47.22%) | 16 (44.44%) |
| Tanner Stage 5 | 5 (62.50%) | 4 (50.00%) |
| ≤25th percentile for age | 152 (56.72%) | 136 (50.37%) |
| Tanner Stage 1 | 66 (61.68%) | 59 (54.63%) |
| Tanner Stage 2 | 54 (69.23%) | 47 (60.26%) |
| Tanner Stage 3 | 19 (48.72%) | 17 (43.59%) |
| Tanner Stage 4 | 10 (27.78%) | 9 (25.00%) |
| Tanner Stage 5 | 3 (37.50%) | 3 (37.50%) |
| Weight | ||
| ≤50th percentile for age | 179 (66.54%) | |
| Tanner Stage 1 | 74 (69.16%) | |
| Tanner Stage 2 | 65 (83.33%) | |
| Tanner Stage 3 | 22 (56.41%) | |
| Tanner Stage 4 | 15 (41.67%) | |
| Tanner Stage 5 | 3 (37.50%) | |
| ≤25th percentile for age | 112 (41.64%) | |
| Tanner Stage 1 | 50 (46.73%) | |
| Tanner Stage 2 | 43 (55.13%) | |
| Tanner Stage 3 | 11 (28.21%) | |
| Tanner Stage 4 | 8 (22.22%) | |
| Tanner Stage 5 | 0 (0.00%) |
Multivariate Linear Regression relationship between tanner stage and reproductive hormone levels for boys in the rural Western Cape after adjusting for lived on farm or not, family income, general health condition, and ever had any testicular related problems.
| Outcomes | B-Coefficient | 95% Confidence Interval | ||
|---|---|---|---|---|
| FSH | ||||
| Tanner Stage 2 vs. Stage 1 | 170 | <0.001 | 1.034 | (0.554; 1.514) |
| Tanner Stage 3 vs. Stage 2 | 110 | <0.001 | 1.416 | (0.765; 2.067) |
| Tanner Stage 4 vs. Stage 3 | 72 | <0.001 | 1.821 | (0.986; 2.657) |
| Tanner Stage 5 vs. Stage 4 | 41 | 0.287 | −0.697 | (−1.985; 0.590) |
| LH | ||||
| Tanner Stage 2 vs. Stage 1 | 172 | <0.001 | 0.545 | (0.309; 0.781) |
| Tanner Stage 3 vs. Stage 2 | 111 | <0.001 | 1.163 | (0.843; 1.484) |
| Tanner Stage 4 vs. Stage 3 | 71 | <0.001 | 0.963 | (0.545; 1.380) |
| Tanner Stage 5 vs. Stage 4 | 40 | 0.805 | 0.080 | (−0.558; 0.718) |
| Oestradiol | ||||
| Tanner Stage 2 vs. Stage 1 | 173 | 0.07 | 6.120 | (−0.494; 12.733) |
| Tanner Stage 3 vs. Stage 2 | 112 | <0.001 | 19.993 | (10.968; 29.018) |
| Tanner Stage 4 vs. Stage 3 | 72 | 0.022 | 13.621 | (2.011; 25.230) |
| Tanner Stage 5 vs. Stage 4 | 41 | 0.006 | 25.320 | (7.430; 43.210) |
| Testosterone | ||||
| Tanner Stage 2 vs. Stage 1 | 174 | 0.186 | 0.548 | (−0.266; 1.363) |
| Tanner Stage 3 vs. Stage 2 | 111 | <0.001 | 5.237 | (4.127; 6.347) |
| Tanner Stage 4 vs. Stage 3 | 72 | <0.001 | 3.347 | (1.922; 4.772) |
| Tanner Stage 5 vs. Stage 4 | 41 | <0.001 | 4.621 | (2.425; 6.818) |
| SHBG | ||||
| Tanner Stage 2 vs. Stage 1 | 172 | 0.008 | −13.531 | (−23.454; −3.608) |
| Tanner Stage 3 vs. Stage 2 | 111 | <0.001 | −38.669 | (−52.146; −25.191) |
| Tanner Stage 4 vs. Stage 3 | 71 | 0.009 | −23.341 | (−40.904; −5.778) |
| Tanner Stage 5 vs. Stage 4 | 40 | 0.999 | 0.023 | (−26.805; 26.850) |
Levels of gonadotropins during sexual development in this study compared with other published studies.
| Study | Country | Study Type | Summary Statistics | FSH (IU/L) | LH(IU/L) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tanner Stage 1 | Tanner Stage 2 | Tanner Stage 3 | Tanner Stage 4 | Tanner Stage 5 | Tanner Stage 1 | Tanner Stage 2 | Tanner Stage 3 | Tanner Stage 4 | Tanner Stage 5 | ||||
| Current study | South Africa | C-S | Median | 0.9 | 1.9 * | 3.1 * | 5.0 * | 3.4 | 0.05 | 0.7 * | 1.65 * | 3.0 * | 2.8 |
| IQR | 0.5–1.5 | 1.3–3.1 | 2.3–4.9 | 3.2–7.5 | 3.2–7.0 | 0.05–0.2 | 0.2–1.0 | 1.3–2.1 | 1.8–4.2 | 1.9–3.8 | |||
| 98 | 72 | 38 | 34 | 7 | 99 | 73 | 38 | 33 | 7 | ||||
| Andersson et al. [ | Denmark | C-S | Median | 0.85 | 1.95 * | 3.50 * | 3.61 | 3.1 | 0.08 | 0.88 * | 2.03 * | 2.89 * | 3.40 * |
| 90% PI | 0.25–2.55 | 0.07–4.39 | 0.94–9.68 | 1.98–6.88 | 1.38–7.52 | 0.05–0.99 | 0.11–2.97 | 0.51–5.42 | 1.11–5.89 | 1.53–6.33 | |||
| 154 | 47 | 27 | 31 | 128 | 154 | 47 | 26 | 31 | 129 | ||||
| Raivio et al. [ | Finland | L | Mean | 1.8 | 1.8 | 1.9 | 2.9 | 3 | 0.3 | 1.1 | 1.4 | 2 | 2.7 |
| ±SD | 1.2–2.6 | 1.2–2.8 | 1.2–3.1 | 1.7–4.9 | 1.8–4.9 | 0.1–0.8 | 0.5–2.3 | 0.8–2.5 | 1.3–3.0 | 1.6–4.5 | |||
| 16 | 37 | 37 | 37 | 16 | 37 | 37 | 37 | ||||||
| Crofton et al. [ | Ireland | L | Median | 1.2 | 2.2 | 2.7 * | 3.5 | 4.2 | |||||
| IQR | 1.0–2.1 | 1.6–2.9 | 1.9–3.3 | 2.7–5.0 | 3.7–5.1 | ||||||||
| 90 | 38 | 39 | 18 | 10 | |||||||||
| Chada et al. [ | Czech Republic | C-S | Mean | 0.42 | 0.85 | 1.46 | 2.3 | 0.21 | 0.61 | 1.23 | 3.17 | ||
| Min–Max | 0.20–0.58 | 0.21–1.48 | 0.49–2.63 | 0.93–3.65 | 0.10–0.44 | 0.12–1.43 | 0.45–2.39 | 1.05–5.54 | |||||
| 11 | 8 | 12 | 10 | 11 | 8 | 12 | 10 | ||||||
L: longitudinal; C-S: cross-sectional; IQR: interquartile range; N: number of boys; PI: predict interval; SD: standard deviation; *: Significance is indicated when the median is statistically significant different from the median of the preceding stage of puberty (p < 0.05). FSH and LH were measure by a time-resolved immunofluorometric assay in the Danish and Finnish study, chemiluminescent microparticle immunoassay (CMIA) in the Czech study, and immunoradiometric assay in the Irish study. In the Danish study, a testicular volume greater than 3 mL was taken as a sign of the onset of puberty; the Czech study used Tanner Stage 1 as onset of puberty and in the Irish study Tanner Stage 2 was used as onset of puberty. The onset of puberty was not used in the Finnish study. Adult reference range used in study laboratory for FSH: 1.5–12.4 IU/L and for LH: 1.7–8.6 IU/L.
Levels of sex steroids during sexual development in this study compared with other published studies.
| Study | Country | Study Type | Summary Statistics | Testosterone (nmol/L) | Oestradiol (pmol/L) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tanner Stage 1 | Tanner Stage 2 | Tanner Stage 3 | Tanner Stage 4 | Tanner Stage 5 | Tanner Stage 1 | Tanner Stage 2 | Tanner Stage 3 | Tanner Stage 4 | Tanner Stage 5 | ||||
| Current study | South Africa | C-S | Median | 0.05 | 0.2 | 3.9 * | 10.5 * | 12.9 * | 31.5 | 40.5 | 56.5 * | 79.4 * | 100.9 * |
| IQR | 0.05–0.1 | 0.05–0.6 | 1.6–8.4 | 5.4–13.6 | 10–18.9 | 23.1–45.5 | 29.7–50.4 | 46.1–72.2 | 61.5–88.5 | 87.2–115.2 | |||
| 101 | 73 | 38 | 34 | 7 | 99 | 74 | 38 | 34 | 7 | ||||
| Andersson et al. [ | Denmark | C-S | Median | 0.2 | 1.9 * | 8.4 * | 17.2 * | 21.0 * | 18 | 21.0 * | 36.0 * | 59.0 * | 71.0 * |
| 90% PI | 0.2–0.9 | 0.2–13.4 | 0.9–21.2 | 7.7–26.5 | 11.3–32.3 | 18.0–34.0 | 18.0–45.0 | 18.0–85.0 | 29.0–102.0 | 44.0–117.0 | |||
| 155 | 47 | 27 | 31 | 130 | 154 | 46 | 25 | 31 | 129 | ||||
| Raivio et al. [ | Finland | L | Mean | 0.4 | 1.4 | 3.9 | 18.1 | 35.4 | |||||
| ±SD | 0.2–0.9 | 0.6–3.4 | 1.6–9.4 | 8.0–41.0 | 23.0–55.0 | ||||||||
| 16 | 37 | 37 | 37 | ||||||||||
| Crofton et al. [ | Ireland | L | Median | 0.3 | 0.9 * | 6.2 * | 15.5 | 18.4 | |||||
| IQR | 0.3–0.5 | 0.5–1.7 | 3.0–11.2 | 10.2–21.0 | 15.8–20.0 | ||||||||
| 90 | 38 | 39 | 18 | 10 | |||||||||
| Chada et al. [ | Czech Republic | C-S | Mean | 0.27 | 0.97 | 3.73 | 12.74 | ||||||
| Min–Max | 0.07–0.55 | 0.44–1.85 | 1.52–7.21 | 8.9–18.1 | |||||||||
| 11 | 8 | 12 | 10 | ||||||||||
L, longitudinal; C-S, cross-sectional; IQR, interquartile range; N, number of boys; PI, predict interval; SD, standard deviation; *: Significance is indicated when the median is statistically significant different from the median of the preceding stage of puberty (p < 0.05). Testosterol levels were measured by radioimmunoassay (RIA) for all overseas studies. Oestradiol levels were measured by radioimmunoassay (RIA) in the Danish study. Adult reference range used in study laboratory for testosterone: 8.4–28.8 nmol/L and for oestradiol: 28–156 pmol/L.